Synopsis
The European Aortic Data Collection (EADC) is a prospective, post-market, multi-centre observational study conducted across Europe.
The primary objective of the EADC is to collect patient-level data on Cook’s custom-made devices (CMDs), also known as patient-specific devices. This data helps assess the clinical safety and performance of endovascular treatments for complex aortic disease using Cook’s CMDs.
Since May 2023, the EADC has enrolled almost 800 patients across 18 sites with Prof. Stéphan Haulon serving as the principal investigator (PI).
In the video, Prof. Haulon discusses the study’s significance and the importance of collecting robust clinical data to evaluate product performance, drive innovation, and improve patient care.
Transcript
(0:10)
The European Aortic Data Collection: It’s a prospective, post-market, multi-centre observational study that we’re conducting across Europe.
(0:19)
The primary goal is to collect patient-level data on Cook custom-made device[s], otherwise known as a patient-specific device, also referred [to] as CMDs.
(0:29)
I am the PI of that study and [am] working with a group of physician[s] that have a high level of experience with complex aortic endografting.
(0:38)
This is from the arch… all the way down to the iliacs.
(0:44)
This helps to evaluate clinical safety and performance, the outcomes of endovascular treatment of complex aortic disease, using Cook CMDs.
(0:53)
We started the enrolment late May 2023, and we have already enrolled more than 500 patients. And 18 sites across Europe are enrolling, including Germany, UK, France, Italy, Sweden and Denmark.
(1:13)
Now we are—with those 500 patients we are now focusing on translating that data and planning publications.
(1:20)
What is nice is now that we have gathered over 500 patients’ dataset[s], we can start looking at the results and start sharing the initial EADC experience.
(1:32)
The importance of the collection of robust data for this type of procedures is vital.
(1:38)
Initiatives like this are critical for a few reasons.
(1:40)
So one, that data ensures that we understand how products perform in diverse patient populations and clinical settings.
(1:48)
And two, this data allows [us] to continue to focus on patient outcomes, refining and innovating treatment options with patients in mind.
(1:58)
Now this is where collaboration really shines between HCPs and Cook, as an innovative company, to ensure that we understand the data and translate it into best practices for patients.
(2:10)
Cook plays a vital role with EADC providing the resources and coordination needed to ensure that the study runs smoothly, because we need accurate data so that we can make the right decisions for our patients.
(2:23)
Something very special about EADC is how a small group of dedicated physicians are really focusing on making sure that the data is appropriate.
(2:32)
We will need this data to change our practice in the future or to support what we are currently doing.
(2:38)
So we want to make sure that we have the correct data to analyse.
(2:43)
So there’s a huge effort from Cook, HCPs, and us physician[s] to make sure that we are analysing the correct data and sharing it with the medical community.